<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873780</url>
  </required_header>
  <id_info>
    <org_study_id>BE403201317621</org_study_id>
    <nct_id>NCT02873780</nct_id>
  </id_info>
  <brief_title>Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients</brief_title>
  <official_title>Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in Chronic Obstructive Pulmonary Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier des Pays de Morlaix</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier des Pays de Morlaix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare oxygen desaturation during two tests: the 6 minute walk
      test and the 3 minute step test, for COPD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 6 minute walk test (6MWT) is the best field test to determine oxygen desaturation during
      effort, in COPD patients. However, the test need a 30m corridor.

      The 3 minute step test (3MST) is a other field test used in COPD patients. But no study shows
      that 3MST can be used to determine oxygen desaturation.

      The aim of this study is to compare oxygen desaturation during these to tests : the 6MWT and
      the 3MST.

      50 patients will be included in this study.

      Patients realize two 6MWT and two 3MST, with rest between each test.

      Oxygen saturation, heart rate are registered during the tests, dyspnea, leg peniblility are
      notified before and after each test, distance or number of steps are noted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>3 minutes</time_frame>
    <description>oxygen saturation is compared between 6MWT and 3MST at the end of the 2 tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>3 minutes</time_frame>
    <description>heart rate is compared between 6MWT and 3MST at the end of the 2 tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dyspnea (Borg Scale)</measure>
    <time_frame>3 minutes</time_frame>
    <description>dyspnea (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>leg penibility (Borg Scale)</measure>
    <time_frame>3 minutes</time_frame>
    <description>leg penibility (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests</description>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>COPD</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients hospitalized for pulmonary rehabilitation program
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable COPD patients hospitalized for pulmonary rehabilitation program

        Exclusion Criteria:

          -  acute exacerbation of COPD

          -  incapacity to realize the tests

          -  absence of written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Beaumont, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>France, Britain, CH Des Pays de Morlaix</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory Reychler, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Belgium, Cliniques universitaires de Saint Luc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH Des pays de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <zip>29600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Roberts MM, Cho JG, Sandoz JS, Wheatley JR. Oxygen desaturation and adverse events during 6-min walk testing in patients with COPD. Respirology. 2015 Apr;20(3):419-25. doi: 10.1111/resp.12471. Epub 2015 Jan 20.</citation>
    <PMID>25601398</PMID>
  </results_reference>
  <results_reference>
    <citation>Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013 Feb 15;187(4):382-6. doi: 10.1164/rccm.201209-1596OC. Epub 2012 Dec 21.</citation>
    <PMID>23262518</PMID>
  </results_reference>
  <results_reference>
    <citation>Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1428-46. doi: 10.1183/09031936.00150314. Epub 2014 Oct 30. Review.</citation>
    <PMID>25359355</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier des Pays de Morlaix</investigator_affiliation>
    <investigator_full_name>Marc Beaumont</investigator_full_name>
    <investigator_title>physiotherapist</investigator_title>
  </responsible_party>
  <keyword>Pulmonary rehabilitation</keyword>
  <keyword>COPD</keyword>
  <keyword>Evaluation</keyword>
  <keyword>oxygen desaturation</keyword>
  <keyword>exercise capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

